A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects.
Coghlan MJ, Jacobson PB, Lane B, Nakane M, Lin CW, Elmore SW, Kym PR, Luly JR, Carter GW, Turner R, Tyree CM, Hu J, Elgort M, Rosen J, Miner JN.
Coghlan MJ, et al. Among authors: rosen j.
Mol Endocrinol. 2003 May;17(5):860-9. doi: 10.1210/me.2002-0355. Epub 2003 Feb 13.
Mol Endocrinol. 2003.
PMID: 12586843